TSX:WEED (Canopy Growth)
About WEED
Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.
Canopy Growth (TSX: WEED) Latest News

Energy Stocks
3 Top Canadian Stocks to Buy Ahead of Their Earnings

Tech Stocks
These 3 Stocks Had an Amazing January: Should You Buy Now?

Cannabis Stocks
Cannabis Stocks Surge as Aphria (TSX:APHA) Rises 82%

Energy Stocks
2 TSX Stocks to Buy and Hold for the Next 10 Years

Cannabis Stocks
Canopy (TSX:WEED) Stock Is up an Insane 37.2% Already in 2021

Cannabis Stocks
Cannabis: When Will the U.S. Legalize it?

Cannabis Stocks
Can Canopy Growth Stock Continue its Parabolic Move?

Cannabis Stocks
Weed Stocks Are Blowing Up in 2021: Buy or Sell?

Cannabis Stocks
3 Top Cannabis Stocks to Buy Right Now

Coronavirus
Marijuana Investors: Canopy Growth (TSX:WEED) Could Skyrocket Back to All-Time Highs

Coronavirus
2 Great Cannabis Stocks for New Investors
